Cite
HARVARD Citation
Cardone, C. et al. (n.d.). 96PAXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT) + cetuximab in RAS wild type (WT) patients (pts). Annals of oncology. p. . [Online].